Galderma S.A.

Industry

  • Digital Health
    • Disease Management
  • Pharmaceuticals
    • OTC, Consumer
    • Vaccines
    • Drug Delivery
      • Topical Delivery
    • Specialty Pharmaceuticals

Other Names/Subsidiaries

  • ALASTIN Skincare
  • Alastin Skincare
  • CollaGenex Pharmaceuticals
  • Nestle
  • Nestle Skin Health S.A.
  • Nestlé Skin Health
  • Q-Med AB
  • Spirig Pharma AG.
See more in Biomedtracker

Latest on Galderma S.A.

Scrip

Finance Watch: Public Company Fundraising Sank Across The Board In Q1

 
• By Mandy Jackson

Biopharmaceutical companies raised just $13.1bn during the first quarter of 2025 – less than half of the $30.1bn raised in Q1 of 2024, the latest Financing Quarterly Statistics report from Biomedtra

Scrip

Asia Deal Watch: Lilly Partners With Rznomics On Hearing Loss

 
• By Joseph Haas, Xu Hu, Anju Ghangurde, and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Rznomics To Partner With Lilly On

Scrip

Finance Watch: Cargo Restructuring Not The News The IPO Market Needs

 
• By Mandy Jackson

Cargo Therapeutics’ decision to end all development for its allogeneic cell therapy technology platform and its cancer cell therapy candidates is not the kind of news the biopharmaceutical sector need

Scrip

Almirall Predicts Plenty More Growth In Psoriasis

 
• By Kevin Grogan

A decade ago, Almirall took the strategic decision to focus exclusively on medical dermatology, and after posting a strong set of financials for 2024, CEO Carlos Gallardo has told investors that “I’m